Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

about

Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.

P2860

Q39210337-608DB3B7-1586-47E4-8865-FC4455F41CAF

P2860

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

Item

http://www.wikidata.org/entity/Q47802987

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

@en

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

@nl

type

Item

label

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

@en

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

@nl

prefLabel

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

@en

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

@nl

P1476

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

@en

P2093

Calin D Popa

http://www.w3.org/2001/XMLSchema#string

Elke E Arts

http://www.w3.org/2001/XMLSchema#string

Jaap Fransen

http://www.w3.org/2001/XMLSchema#string

Jake S F Maurits

http://www.w3.org/2001/XMLSchema#string

Piet L C M van Riel

http://www.w3.org/2001/XMLSchema#string

Wietske Kievit

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study

Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

An introduction to Markov modelling for economic evaluation.

Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands.

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.

Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

The mortality of rheumatoid arthritis.

P304

175-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.22929

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27159060

http://www.w3.org/2001/XMLSchema#string

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

about

P2860

P2860

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698